Shin Nippon Biomedical Laboratories, Ltd. (2395) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Mitsubishi Research Institute, Inc.

Bengo4.com, Inc.

insource Co., Ltd.

Prestige International Inc.

TRYT, Inc.

SBS Holdings, Inc.

GMO Financial Gate, Inc.

eGuarantee, Inc.

INTAGE HOLDINGS, Inc.

TKP Corp.

Shin Nippon Biomedical Laboratories, Ltd.

Why is Shin Nippon Biomedical Laboratories, Ltd. ?

With a fall in Operating Profit of -21.87%, the company declared Very Negative results in Dec 25

ROCE(HY) Lowest at 8.16%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.01 times
NET SALES(Q) Lowest at JPY 6,429.09 MM

Below par performance in long term as well as near term

Along with generating -4.09% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shin Nippon Biomedical Laboratories, Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shin Nippon Biomedical Laboratories, Ltd.

-4.09%

0.12

43.27%

Japan Nikkei 225

36.73%

1.30

28.24%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

17.36%

EBIT Growth (5y)

15.06%

EBIT to Interest (avg)

26.69

Debt to EBITDA (avg)

1.88

Net Debt to Equity (avg)

0.85

Sales to Capital Employed (avg)

0.45

Tax Ratio

19.10%

Dividend Payout Ratio

42.27%

Pledged Shares

Institutional Holding

ROCE (avg)

12.04%

ROE (avg)

24.18%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.40

EV to EBIT

30.12

EV to EBITDA

15.02

EV to Capital Employed

1.26

EV to Sales

2.41

PEG Ratio

Dividend Yield

ROCE (Latest)

4.18%

ROE (Latest)

12.32%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -24.51% (YoY

CASH AND EQV(HY)

Highest at JPY 26,965.15 MM

OPERATING PROFIT MARGIN(Q)

Highest at 28.9 %

-26What is not working for the Company

ROCE(HY)

Lowest at 8.16%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.01 times

NET SALES(Q)

Lowest at JPY 6,429.09 MM

INTEREST(Q)

Highest at JPY 78.15 MM

PRE-TAX PROFIT(Q)

Fallen at -37.38%

NET PROFIT(Q)

Fallen at -35.59%

Here's what is working for Shin Nippon Biomedical Laboratories, Ltd.

Operating Profit Margin

Highest at 28.9 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Cash and Eqv

Highest at JPY 26,965.15 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -24.51% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at JPY 879.26 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Shin Nippon Biomedical Laboratories, Ltd.

Net Sales

At JPY 6,429.09 MM has Fallen at -33.9%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (JPY MM)

Interest

At JPY 78.15 MM has Grown at 13.86%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Sales

Lowest at JPY 6,429.09 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (JPY MM)

Interest

Highest at JPY 78.15 MM

in the last five periods and Increased by 13.86% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Pre-Tax Profit

Fallen at -37.38%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Fallen at -35.59%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

Inventory Turnover Ratio

Lowest at 1.01 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio